BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36037675)

  • 1. Involvement of Xeroderma Pigmentosum Complementation Group G (XPG) in epigenetic regulation of T-Helper (T
    Pal R; Rakshit S; Shanmugam G; Paul N; Bhattacharya D; Chatterjee A; Singh A; George M; Sarkar K
    Immunobiology; 2022 Sep; 227(5):152259. PubMed ID: 36037675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC).
    Mukherjee O; Paul S; Das S; Rakshit S; Shanmugam G; George M; Sarkar K
    Pathol Res Pract; 2024 Jan; 253():155004. PubMed ID: 38086291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
    Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
    Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPG in the Nucleotide Excision Repair and Beyond: a study on the different functional aspects of XPG and its associated diseases.
    Pal R; Paul N; Bhattacharya D; Rakshit S; Shanmugam G; Sarkar K
    Mol Biol Rep; 2022 Aug; 49(8):7995-8006. PubMed ID: 35596054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory Role of Diospyros peregrina Fruit Preparation in Breast Cancer by Utilizing Macrophage Mediated Antigen Presentation and T Helper Cell (Th) Differentiation.
    Mahalakshmi Surendran A; Rai A; Rakshit S; George M; Sarkar K
    Clin Breast Cancer; 2023 Apr; 23(3):e95-e102. PubMed ID: 36641322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stable XPG protein is required for proper ribosome biogenesis: Insights on the phenotype of combinate Xeroderma Pigmentosum/Cockayne Syndrome patients.
    Taupelet F; Donnio LM; Magnani C; Mari PO; Giglia-Mari G
    PLoS One; 2022; 17(7):e0271246. PubMed ID: 35802638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPG: a multitasking genome caretaker.
    Muniesa-Vargas A; Theil AF; Ribeiro-Silva C; Vermeulen W; Lans H
    Cell Mol Life Sci; 2022 Mar; 79(3):166. PubMed ID: 35230528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity.
    Lalle P; Nouspikel T; Constantinou A; Thorel F; Clarkson SG
    J Invest Dermatol; 2002 Feb; 118(2):344-51. PubMed ID: 11841555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of XPG protein in human normal and tumor tissues.
    Aracil M; Dauffenbach LM; Diez MM; Richeh R; Moneo V; Leal JF; Fernández LF; Kerfoot CA; Galmarini CM
    Int J Clin Exp Pathol; 2013; 6(2):199-211. PubMed ID: 23330005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC).
    Chandnani N; Choudhari VS; Talukdar R; Rakshit S; Shanmugam G; Guchait S; Gupta I; George M; Sarkar K
    Med Oncol; 2023 May; 40(7):185. PubMed ID: 37212947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDR1-EXPRESSING CD4
    Di Roio A; Hubert M; Besson L; Bossennec M; Rodriguez C; Grinberg-Bleyer Y; Lalle G; Moudombi L; Schneider R; Degletagne C; Treilleux I; Campbell DJ; Metzger S; Duhen T; Trédan O; Caux C; Ménétrier-Caux C
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37940345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC.
    Verma C; Eremin JM; Robins A; Bennett AJ; Cowley GP; El-Sheemy MA; Jibril JA; Eremin O
    J Transl Med; 2013 Jan; 11():16. PubMed ID: 23320561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human XPG nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations.
    Tsutakawa SE; Sarker AH; Ng C; Arvai AS; Shin DS; Shih B; Jiang S; Thwin AC; Tsai MS; Willcox A; Her MZ; Trego KS; Raetz AG; Rosenberg D; Bacolla A; Hammel M; Griffith JD; Cooper PK; Tainer JA
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14127-14138. PubMed ID: 32522879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
    Bartolucci R; Wei J; Sanchez JJ; Perez-Roca L; Chaib I; Puma F; Farabi R; Mendez P; Roila F; Okamoto T; Taron M; Rosell R
    Clin Lung Cancer; 2009 Jan; 10(1):47-52. PubMed ID: 19289372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma.
    Italiano A; Laurand A; Laroche A; Casali P; Sanfilippo R; Le Cesne A; Judson I; Blay JY; Ray-Coquard I; Bui B; Coindre JM; Nieto A; Tercero JC; Jimeno J; Robert J; Pourquier P
    Cancer; 2011 Aug; 117(15):3445-56. PubMed ID: 21287534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene.
    Harada YN; Shiomi N; Koike M; Ikawa M; Okabe M; Hirota S; Kitamura Y; Kitagawa M; Matsunaga T; Nikaido O; Shiomi T
    Mol Cell Biol; 1999 Mar; 19(3):2366-72. PubMed ID: 10022922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients.
    Saleh ME; Gadalla R; Hassan H; Afifi A; Götte M; El-Shinawi M; Mohamed MM; Ibrahim SA
    PLoS One; 2019; 14(5):e0217550. PubMed ID: 31145753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells.
    zum Büschenfelde CM; Metzger J; Hermann C; Nicklisch N; Peschel C; Bernhard H
    J Immunol; 2001 Aug; 167(3):1712-9. PubMed ID: 11466395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency in the nuclease activity of xeroderma pigmentosum G in mice leads to hypersensitivity to UV irradiation.
    Tian M; Jones DA; Smith M; Shinkura R; Alt FW
    Mol Cell Biol; 2004 Mar; 24(6):2237-42. PubMed ID: 14993263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.